Prostate Clinical Trial
Official title:
A Neighborhood-Based Intervention to Reduce Prostate Cancer Disparities
Verified date | January 2020 |
Source | Thomas Jefferson University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical trial studies how well an educational intervention works in increasing knowledge about prostate cancer in high-risk neighborhoods. Learning about prostate cancer and the pros and cons of screening for prostate cancer may increase knowledge about prostate cancer while decreasing anxiety and concerns about prostate cancer screening.
Status | Active, not recruiting |
Enrollment | 296 |
Est. completion date | May 1, 2021 |
Est. primary completion date | January 4, 2019 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 40 Years to 69 Years |
Eligibility |
Inclusion Criteria: - Focus groups consisting of men who live, work, or worship in the 4 predetermined neighborhoods - Currently reside in one of the four selected high risk neighborhoods Exclusion Criteria: • Men who do not reside in one of the four neighborhoods, who self-report that they have previously been diagnosed with prostate cancer, or who have had prostate cancer screening (prostatic specific antigen [PSA] or digital rectal examination [DRE]) within the past 12 months |
Country | Name | City | State |
---|---|---|---|
United States | Sidney Kimmel Cancer Center at Thomas Jefferson University | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Sidney Kimmel Cancer Center at Thomas Jefferson University | United States Department of Defense |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Themes identified by focus group transcripts | Focus group transcripts will be analyzed by iterative rounds of coding by at least two members of the research team. Specific themes and trends will be identified within each transcript and discussed by the research team until final consensus is reached. Themes will be identified as topics that consistently occur across transcripts, as well as similarities and differences between transcripts. | Up to 4 years | |
Primary | Change in prostate cancer knowledge as measured by a 17-item scale | Descriptive analyses will be used including t-test, frequency tables, nonparametric tests, correlations, regression models. Linear and generalized linear mixed models having random intercepts corresponding to neighborhood will be applied. | Baseline to up to 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00026689 -
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
|
||
Completed |
NCT00547625 -
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
|
Phase 2 | |
Completed |
NCT00648323 -
Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement
|
Phase 4 | |
Completed |
NCT00579423 -
Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
|
Phase 2 | |
Completed |
NCT00342433 -
Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
|
||
Active, not recruiting |
NCT03047135 -
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
|
Phase 2 | |
Enrolling by invitation |
NCT06364865 -
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
|
||
Terminated |
NCT03197948 -
Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
|
||
Completed |
NCT00586898 -
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
|
Phase 2 | |
Recruiting |
NCT04518072 -
Synthetic Metabolic and Genetic Networks for Medical Diagnosics
|
||
Completed |
NCT01118260 -
Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
|
Phase 4 | |
Recruiting |
NCT00923221 -
Collection of Blood From Patients With Prostate Cancer
|
||
Active, not recruiting |
NCT01078662 -
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
|
Phase 2 | |
Completed |
NCT00423254 -
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
|
Phase 1 | |
Terminated |
NCT02918227 -
Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT05509114 -
The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction
|
N/A | |
Completed |
NCT02756975 -
Prostate Core Needle Biopsy
|
N/A | |
Active, not recruiting |
NCT00572468 -
Statin Therapy Versus Placebo Prior to Prostatectomy
|
N/A | |
Completed |
NCT00364455 -
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.
|
Phase 3 | |
Terminated |
NCT03318367 -
Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy
|
N/A |